Children and adolescents treated for TB in past 2 years

Given the increased risk of treatment failure and drug resistance, children and adolescents who had been treated in the preceding 2 years were not eligible for inclusion in the SHINE trial. These children should be treated with the 6-month treatment regimen (2HRZ(E)/4HR).

Book navigation